COVID-19 Vaccination in Rheumatic Disease Patients
Immunological Consequences of COVID-19 Vaccination in Patients With Rheumatic Diseases
Sponsor: Mayo Clinic
Terminated
Difficulty with enrollment
Other terminated trials from Mayo Clinic
Other Ankylosing Spondylitis trials with similar outcome
This EARLY_PHASE1 trial investigates Ankylosing Spondylitis and Arthritis of Multiple Sites Associated With Inflammatory Bowel Disease (Diagnosis) and is currently terminated or withdrawn. Mayo Clinic leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated EARLY_PHASE1
-
Jul 2022 — Jul 2024 [monthly]
Terminated EARLY_PHASE1
Status: Active Not Recruiting → Terminated
-
May 2022 — Jul 2022 [monthly]
Active Not Recruiting EARLY_PHASE1
Status: Recruiting → Active Not Recruiting
-
Apr 2022 — May 2022 [monthly]
Recruiting EARLY_PHASE1
▶ Show 1 earlier version
-
May 2021 — Apr 2022 [monthly]
Recruiting EARLY_PHASE1
First recorded
Feb 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mayo Clinic
For direct contact, visit the study record on ClinicalTrials.gov .